Pain Education Program Is Under Development

Published Online: Saturday, January 1, 2005

As a result of recent events concerning analgesic medications, the American Society of Pain Educators (ASPE) is developing a pain-education training program for pharmaceutical sales representatives. The goal of the program is to support sales representatives and medical liaisons by providing the most current information regarding pain management therapies to prescribing physicians. The training will also offer the representatives the opportunity to become Certified Pain Specialty Representatives.

"Prescribing clinicians look to sales representatives for quick access to important information. Training them with a fair-balanced curriculum will help them help the busy practitioners stay current in a regulatory-challenged world," said B. Eliot Cole, MD, MPA, executive director of the ASPE.

Latest Articles
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Poor medication adherence is responsible for unnecessary illness, hospitalizations, disability, and premature death, particularly among patients with chronic diseases.
Latest Issues